Chronic Myelogenous Leukemia
Treatment for chronic myelogenous leukemia: the long road to imatinib
... The scientists of today have become accustomed to the extremely rapid pace of progress in the biomedical sciences spurred on by the discovery of recombinant DNA and the advent of automated DNA sequencing and PCR, with ...
9
Function of Neutrophils in Different Phases of Chronic Myelogenous Leukemia
... In chronic myelogenous leukemia (CML), the mature granulocytes originate from a stem cell line harboring an abnormal chromosome, therefore it is possible that metabolic-functional abnormalities occur ...
6
Spotlight on nilotinib in the treatment of chronic myelogenous leukemia
... (Ph+) leukemia refractory to prior tyrosine kinase inhibitor (TKI) therapy: results from Nilotinib compassionate use ...(Ph+) chronic myelogenous leukemia (CML) or acute lymphoblastic ...
7
Biomarkers for determining the prognosis in chronic myelogenous leukemia
... B-cell chronic lymphocytic leukemia/lymphoma 2; BCR: Breakpoint cluster region; BELA: Bosutinib Efficacy and Safety in Newly Diagnosed CML; CCyR: Complete cytogenetic response; CDK4: Cyclin-dependent kinase ...
9
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia
... Imatinib-insensitive leukemia stem cells (LSCs) are believed to be responsible for resistance to BCR-ABL tyrosine kinase inhibitors and relapse of chronic myelogenous leukemia ...
21
Bosutinib in the management of chronic myelogenous leukemia
... with chronic, accelerated, or blast-phase Philadelphia chromosome-positive chronic myelogenous leukemia who are intolerant of or resistant to first- or second-generation tyrosine kinase ...in ...
8
Congenital Juvenile Chronic Myelogenous Leukemia: Case Report and Review
... This patient is the youngest reported to have the juvenile form of chronic myelogenous leukemia and the first that in the present era can be considered con- genital in origin.. Pediatric[r] ...
5
Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
... Abstract: Chronic myelogenous leukemia (CML) is a pluripotent stem cell disease characterized by the presence of the Philadelphia chromosome and the bcr-abl ...in chronic phase CML is now ...
9
Treatment of marrow stroma with interferon alpha restores normal beta 1 integrin dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors Role of MIP 1 alpha
... Treatment of marrow stroma with interferonalpha restores normal beta 1 integrin-dependent adhesion of chronic myelogenous leukemia hematopoietic progenitors.. Role of MIP-1 alpha.[r] ...
10
Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome positive chronic myelogenous leukemia (CML) Amplification of rearranged c abl oncogenes in CML blast crisis
... positive chronic myelogenous leukemia (CML) samples by Southern blot hybridization to determine the location of the breakpoints that occur on chromosomes 9 and 22 in the Ph1 ...
6
Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia
... Abstract: Leukemia is a cancer of the white blood ...with leukemia are unaware of their disease until routine blood work up for other conditions reveals incidental findings leading to a diagnosis of ...with ...
7
Heterogeneity of leukemia initiating capacity of chronic myelogenous leukemia stem cells
... Chronic myelogenous leukemia (CML) results from transformation of a long-term hematopoietic stem cell (LTHSC) by expression of the BCR-ABL fusion ...heterogeneous leukemia-initiating capacity ...
18
PHILADELPHIA CHROMOSOME IN PRETHERAPEUTIC CASES OF CHRONIC MYELOGENOUS LEUKEMIA
... ABSTRACT: Chronic myeloid leukemia (CML) is a clonal myel0 proliferative disorder due to neoplastic transformation of myeloid stem ...in chronic phase who are treated with cytotoxic agents eventually ...
15
Lymphoblastic Conversion in Chronic Myelogenous Leukemia
... Recently Moore’7 published data concerning soft agar culture growth parameters in 36 patients during the blast crisis phase of Ph’ chromosome- positive CML and has been able to separate [r] ...
6
A novel BCR-ABL1 fusion gene with genetic heterogeneity indicates a good prognosis in a chronic myeloid leukemia case
... Background: Chronic myelogenous leukemia (CML) is a pluripotent hematopoietic stem cell disorder caused by the fusion of the BCR and ABL1 genes. Quantitative RT-PCR (qRT-PCR) is a routinely performed ...
5
STEROID MEDIATED CHANGES OF LEUCOCYTE ALKALINE PHOSPHATASE ACTIVITY IN DOWN'S SYNDROME
... seen in chronic myelogenous leukemia (CML) associated with the deletion of a portion of chromosome 21 (Philadelphia.. Leucocyte isolation and enzyme assay as in methods. The zero hour p [r] ...
9
Successful Treatment of Juvenile Chronic Granulocytic Leukemia With Marrow Transplantation
... The success with the patient described here suggests that marrow transplanta- lion should be considered for a patient with juvenile chronic myelogenous leukemia who has a matched sibling[r] ...
5
Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor
... 15. Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, Schiffer CA, Talpaz M, Guilhot F, Deininger MW, Fischer T, O ’ Brien SG, Stone RM, Gambacorti-Passerini CB, Russell NH, Reiffers JJ, Shea TC, ...
7
Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib
... Chronic myelogenous leukemia (CML) is a clonal disorder caused by the malignant transformation of a pluripotent hematopoietic stem ...lymphoblastic leukemia (ALL), and in 2% of acute ...
10
Identification of TCR Vβ11-2-Dβ1-Jβ1-1 T cell clone specific for WT1 peptides using high-throughput TCRβ gene sequencing
... Chronic myelogenous leukemia (CML) is a common hematological malignancy in adults and has the molecu- lar characteristic of BCR-ABL fusion proteins, which exhibit abnormal kinase activity ...
8